Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "APS"

878 News Found

Aakash Healthcare publishes landmark study on integrated emergency clinical codes
Hospitals | May 01, 2026

Aakash Healthcare publishes landmark study on integrated emergency clinical codes

Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals


Inside India’s qPCR Transformation: Scale, Shift, and Structural Change
Opinion | May 01, 2026

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine


Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore
News | May 01, 2026

Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore

Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets


BD, Suttons Creek partner to streamline combination product development
R&D | April 30, 2026

BD, Suttons Creek partner to streamline combination product development

The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration


Gen Z split on AI as global study reveals rising tech optimism
Technology | April 30, 2026

Gen Z split on AI as global study reveals rising tech optimism

Health innovations are viewed more positively than food and agricultural technologies


Pfizer locks in long runway for blockbuster heart drug after key patent settlements
News | April 29, 2026

Pfizer locks in long runway for blockbuster heart drug after key patent settlements

The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031


Zydus wins DCGI nod to launch Phase III trials of new anti-malarial drug Zintrodiazine
Clinical Trials | April 27, 2026

Zydus wins DCGI nod to launch Phase III trials of new anti-malarial drug Zintrodiazine

The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine


NIT Rourkela secures patent for rapid spice adulteration detection system
News | April 27, 2026

NIT Rourkela secures patent for rapid spice adulteration detection system

FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


ShardaCare-Healthcity launches Greater Noida’s first comprehensive cancer care centre
Hospitals | April 25, 2026

ShardaCare-Healthcity launches Greater Noida’s first comprehensive cancer care centre

Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof